Ms Esther Elizabeth King, LPN | |
1001 Rio Vista St, Fallon, NV 89406-5463 | |
(775) 423-3634 | |
(775) 423-3246 |
Full Name | Ms Esther Elizabeth King |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 1001 Rio Vista St, Fallon, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437236866 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | LPN07722 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Esther Elizabeth King, LPN 1001 Rio Vista St, Fallon, NV 89406-5463 Ph: (775) 423-3634 | Ms Esther Elizabeth King, LPN 1001 Rio Vista St, Fallon, NV 89406-5463 Ph: (775) 423-3634 |
News Archive
A team of researchers at the Bosch Institute have identified an important gene responsible for binocular vision.
In a recent breakthrough to combat malaria, a collaboration of Indian and American scientists have identified a malarial parasite protein that can be used to develop antibodies when displayed on novel nanoparticles. This approach has the potential to prevent the parasite from multiplying in the human host and also inhibits transmission through mosquitoes. The finding points towards developing a powerful malaria vaccine in the hope of eradicating this debilitating and often fatal disease.
Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in the POPular study, which was presented during a Late Breaking Clinical Trials session at the American Heart Association's annual Scientific Sessions.
A European study analyzes the relationship between fruit and vegetable consumption and the risk of mortality. As previous research has already suggested, this study concludes that fruit and vegetable consumption reduces all-cause mortality, and especially cardiovascular disease mortality.
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.
› Verified 2 days ago
Jessica Rae Hopkins, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5550 Candee Ln, Fallon, NV 89406 Phone: 307-221-1865 | |
Sharon Ann Shirley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 Rio Vista Dr, Fallon, NV 89406 Phone: 775-423-3634 |